Genomics

Dataset Information

0

Gene expression profiling of ATRA-differentiated wild-type and TG2 knockout NB4 cells


ABSTRACT: Treatment of acute promyelocytic leukemia (APL) with all-trans-retinoic acid (ATRA) results in terminal differentiation of leukemic cells toward neutrophil granulocytes. Administration of ATRA leads to massive changes in gene expression, including down-regulation of cell proliferation-related genes and induction of genes involved in immune function. One of the most induced genes in APL NB4 cells is transglutaminase 2 (TG2). RNAi-mediated stable silencing of TG2 in NB4 cells (TG2-KD NB4) coupled with whole genome microarray analysis revealed that TG2 is involved in the expression of a large number of ATRA-regulated genes. The affected genes participate in granulocyte functions and their silencing lead to reduced adhesive, migratory and phagocytic capacity of neutrophils and less superoxide production. The expression of genes related to cell cycle control also changed, suggesting that TG2 regulates myeloid cell differentiation. CC chemokines CCL2, 3, 22, 24 and cytokines IL1B and IL8 involved in the development of differentiation syndrome (DS) are expressed at significantly lower levels in TG2-KD NB4 cells than in wild-type NB4 cells upon ATRA treatment. Based on our results, we propose that reduced expression of TG2 in differentiating APL cells may suppress effector functions of neutrophil granulocytes and attenuate the ATRA-induced inflammatory phenotype of DS.

ORGANISM(S): Homo sapiens

PROVIDER: GSE23702 | GEO | 2010/12/01

SECONDARY ACCESSION(S): PRJNA130897

REPOSITORIES: GEO

Similar Datasets

| E-GEOD-23702 | biostudies-arrayexpress
| E-GEOD-63059 | biostudies-arrayexpress
2009-11-26 | GSE19201 | GEO
2017-01-20 | GSE93877 | GEO
2017-01-20 | GSE93876 | GEO
| E-GEOD-19201 | biostudies-arrayexpress
| E-GEOD-11379 | biostudies-arrayexpress
2021-05-26 | GSE175507 | GEO
2008-11-18 | GSE11379 | GEO
2014-04-30 | GSE49516 | GEO